TRANSACTIONS - CEC CAPITAL

Cancel

Date：2021-06
/index.php?a=shows&catid=34&id=812
closing of a RMB 200 million Series B+ financing round. The funding was led by Qiming Venture Partners, with participation from BioVenture, C&D Emerging Industry Investment, and existing shareholder Sino-Ocean Capital. CEC Capital Group acted as the e
Cancel

Date：2021-06
/index.php?a=shows&catid=34&id=813
On June 1, 2021, Stemirna announced the closing of a $200 million round of financing, led by China Merchants Capital, HongShan, King Lin investment, and WuXi AppTec, with participation from OrbiMed Advisors, Advantech Capital, Zhejiang Guotong Investment,
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=814
HYGEIA (6078.HK) announced the acquisition of a 98% stake in Suzhou Yongding Hospital for a transaction size of RMB 1.7 billion. With this acquisition, Ascendent Capital, the controlling shareholder of Yongding Hospital, has completely divested its owners
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=815
Genome Grecision, a rare domestic provider specializing in comprehensive molecular diagnostics solutions for hematological diseases, announced the closing of roughly RMB 200 million in Series C financing. This round of financing was jointly led by Sunland
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=566
Bliss Biopharmaceutical (Hangzhou) Co., Ltd. (“BlissBio”) announces the completion of over 400M CNY Series-B financing round. The financing was led by GL Ventures, the venture capital unit of Hillhouse Capital, with participation from Cormorant Asset Management, VMS Group, and Heda Biopharmaceutical Venture Capital. The Series B financing round was also supported by existing investors, Sherpa Healthcare Partners and Oriental Fortune Capital. CEC Capital Group acted as the exclusive financial advisor in the transaction.
Cancel

Date：2021-04

CEC Capital Served as Financial Advisor
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=561
Arrail Group (“Arrail” or the “Company), a leading dental service provider in China, announced that it has closed its Series E financing, with a transaction value of nearly $200M. The transaction was led by Temasek, with participation from OrbiMed, Ward Ferry, Hina Group, Industrial Bank and Mirae Asset. CEC Capital Group was the exclusive financial advisor on this transaction, and is proud to have advised Arrail since its Series A round of financing.
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=818
The innovative artificial joint company b-ONE successfully closed a B-round financing of several hundred of million RMB, marking it the the largest RMB financing in the domestic orthopedic joint sector in recent years. The funding was led by Huatai Zijin
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=819
On April 12, SUNING LSY announced the successful closing of a significant Series A financing with investment from CPE and ADV Partners. CEC Capital Group served as the exclusive financial advisor in this transaction for SUNING LSY.